LONDON , October 22, 2014 /PRNewswire/ -- One of North America's older, more mature plays, the Rocky Mountain's Piceance Basin doesn't get the same media attention as the newcomers, but there is a flurry of game-changing drilling that will render this liquids-rich haven a major rival.
Sign-up for Marani Brands CEO Margrit Eyraud Discusses Expanding 40 Million Dollar Brazilian Contract, New York License Approval and Launch of TV Commercial With Donald Baillargeon of MoneyTV investment picks
Pershing Square Capital Management, L.P. (“Pershing Square”), the
largest shareholder of Allergan, Inc. (NYSE:AGN) (“Allergan”), announced
today that it submitted the required documentation to compel Allergan to
call a special meeting of Allergan shareholders.
In recognition of its innovation on behalf of patients, investments in
product line development, and its rapidly escalating growth, Insys
Therapeutics, Inc., of Chandler, Arizona, was named the 2014 Arizona
Bioscience Company of the Year by the Arizona Bioindustry Association
Insys Therapeutics, Inc. (NASDAQ: INSY) is a commercial-stage specialty
pharmaceutical company based in Chandler, Arizona, that develops and
commercializes innovative supportive care products.
XenoPort, Inc. (Nasdaq:XNPT) and the National Institute on Alcohol Abuse
and Alcoholism (NIAAA) announced today that they have entered into an
agreement to conduct a clinical trial of HORIZANT ®
(gabapentin enacarbil) Extended-Release Tablets as a potential treatment
for alcohol use disorder (AUD). Under the terms of the agreement,
XenoPort will supply clinical trial material and the NIAAA will conduct
and pay all other expenses associated with the proposed clinical trial
NEW YORK, July 25, 2014 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that they have filed a class action lawsuit on behalf of their client and others in the United States District Court for the Central District of California on behalf of all persons who purchased or otherwise acquired the securities of NetSol Technologies, Inc. ("NetSol" or the "Company") (Nasdaq:NTWK) during the period between March 10, 2011 and November 8, 2013, inclusive (the "Class Period") (the "Class Period"). This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the "Exchange Act").
The Complaint alleges that throughout the Class Period, Defendants issued materially false and/or misleading statements because: (a) NetSol's next generation product was not expected to be completed when promised by the Company; (b) serious interest in NetSol's next generation solution had not been
Analysts at Morgan Stanley cautioned Tuesday that General Motors Co.'s (GM) earnings are likely to follow Ford Motor Co.'s (F) path and cut GM's price target to $27 from $29. "We believe many elements from Ford's recent profit warning are applicable to GM's outlook through 2015 and beyond," analyst Adam Jonas said in a report.
Riverbed Technology (NASDAQ:RVBD), the leader in application performance
infrastructure, today announced that Upstate University Health System,
affiliated with the State University of New York (SUNY), is using Riverbed ®
SteelApp TM Traffic Manager virtual application delivery
controller (ADC) to ensure high availability for its electronic health
record (EHR) software from Epic Systems Corporation, which is used by
the entire healthcare organization in every patient-related activity.
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving
science, today announced that it has completed the sale of its
Cole-Parmer customer channel business to private equity firm GTCR LLC
for approximately $480 million in cash.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.